Trial intelligence / Profile preview

Low-dose nitroglycerin for prevention of postoperative acute lung injury in elderly surgical patients

ChiCTR2000038687Phase 4Not yet recruiting

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of nitroglycerin in acute lung injury (ALI) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Incidence of postoperative acute lung injury. Planned start Sep 2020; status: not yet recruiting.

02

Drugs

nitroglycerin
03

Conditions

acute lung injury (ALI)

Beyond the preview

Go deeper on ChiCTR2000038687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call